Cargando…
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis
Type 1 conventional dendritic cells (cDC1s) are typically thought to be dysregulated secondarily to invasive cancer. Here, we report that cDC1 dysfunction instead develops in the earliest stages of preinvasive pancreatic intraepithelial neoplasia (PanIN) in the Kras(LSL-)(G12D/+) Trp53(LSL-)(R172H/+...
Autores principales: | Lin, Jeffrey H., Huffman, Austin P., Wattenberg, Max M., Walter, David M., Carpenter, Erica L., Feldser, David M., Beatty, Gregory L., Furth, Emma E., Vonderheide, Robert H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398166/ https://www.ncbi.nlm.nih.gov/pubmed/32453421 http://dx.doi.org/10.1084/jem.20190673 |
Ejemplares similares
-
Systemic inflammation is a determinant of outcomes of CD40 agonist–based therapy in pancreatic cancer patients
por: Wattenberg, Max M., et al.
Publicado: (2021) -
Dysregulation of Autophagy Contributes to Anal Carcinogenesis
por: Carchman, Evie H., et al.
Publicado: (2016) -
An Emerging Role for Epigenetic Dysregulation in Arsenic Toxicity and Carcinogenesis
por: Ren, Xuefeng, et al.
Publicado: (2011) -
Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation
por: Carpenter, Erica L, et al.
Publicado: (2009) -
Arsenic-Induced Carcinogenesis and Immune Dysregulation
por: Huang, Hsin-Wei, et al.
Publicado: (2019)